3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
85
Endocrine
9
Sarcoma
5
NET
3
Gastrointestinal
3
Thoracic
2
Lymphoid
2
Genitourinary
2
Dermatologic
2
Plasma cell
1
Other hematologic neoplasm
1
Head & Neck
1
Gynecologic
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
885
Precursor Cell Lymphoblastic Leukemia-Lymphoma
511
Hematologic Neoplasms
464
Leukemia, Lymphocytic, Chronic, B-Cell
392
Leukemia
336
Myelodysplastic Syndromes
330
Lymphoma
207
Lymphoma, Non-Hodgkin
191
Multiple Myeloma
146
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
142
Recurrence
138
Neoplasms
135
Leukemia, Myelomonocytic, Chronic
112
Burkitt Lymphoma
93
Lymphoma, Mantle-Cell
92
Lymphoma, Follicular
92
Lymphoma, Large B-Cell, Diffuse
91
Myeloproliferative Disorders
84
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
83
Leukemia, Biphenotypic, Acute
81
Lymphoma, B-Cell, Marginal Zone
75
Hodgkin Disease
72
Lymphoma, B-Cell
64
Waldenstrom Macroglobulinemia
54
Primary Myelofibrosis
54
Leukemia, B-Cell
52
Anemia, Refractory, with Excess of Blasts
46
Leukemia, Myeloid, Chronic-Phase
41
Hematologic Diseases
37
Lymphoma, T-Cell
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningioma
×
Other hematologic neoplasm
×
1 year
×
Clear all
NCT03702309
2025-11-26
LIBERATE
University Health Network, Toronto
Recruiting
2,500 enrolled